Skip to Main Content

The New Mexico attorney general has filed a lawsuit against Gilead Sciences (GILD) and two other major drug makers for allegedly conspiring to block competition to several different HIV medicines, which ultimately caused the state to spend millions of dollars for “excessively overpriced” treatments.

Specifically, the lawsuit details a complicated scheme in which Gilead “deliberately and deceitfully” delayed generic competition for its widely used HIV medicines for several years by, among other things, reaching purportedly anticompetitive agreements with Bristol Myers Squibb (BMY) and Teva Pharmaceuticals (TEVA), which is one of the world’s largest purveyors of generic drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!